A breakthrough in a new class of cancer prevention technology developed by researchers at MIT may one day allow people with certain types of cancer to live for decades longer, as long as their health is preserved.
A team led by MIT’s Robert Koch has developed a system that can turn cells of a person’s own body into an artificial heart or lungs and then inject it with an artificial protein, a key step toward making the heart or lung viable for use in other diseases.
The system, called bioelectronics, could help treat many types of cancers and also protect against the deadly, non-invasive forms of lung cancer that can be caused by smoking, alcohol consumption or other environmental exposures.
The new technology, called BioElectronics, relies on two proteins called ALT2 and ALT3.
The proteins work as a form of chemical signaling in the body, signaling what chemicals are needed for the body to respond.
But in cancer cells, these proteins are often misused and damaged.
When they’re misused, they can cause the cells to grow abnormally, including cancerous tumors.
Researchers have developed ways to prevent or treat these cancerous cells from becoming cancerous.
So far, there are a few treatments that use drugs to suppress the proteins.
The MIT researchers have now created a system to turn the proteins into an actual artificial heart.
The engineered heart can be inserted into a patient’s body through a small hole and then injected.
The artificial heart can pump blood to the patient, and when the artificial heart is healthy, the patient can breathe normally again.
In their study, published in the journal ACS Nano, the researchers used an artificial lung that had been transplanted into a cancer patient.
The lung contained a small patch of the artificial protein and the cancer patient had been injected with a drug that mimics the protein, ALT1, and ALTR2, a second protein found in human cells that helps them regulate their blood pressure.
The cancer patient’s cells then produced more ALTR1 and AL2 to help the artificial lung regulate blood pressure and to make the patient’s lungs and tissues grow abnormality-free.
To see if this approach would work, the MIT team used the artificial organ to create the artificial lungs.
The cells were grown in the laboratory, and the artificial organs were injected into the patient.
They then observed the cells developing abnormally in the patient for several months.
The researchers did not see any signs of cancer cells growing inside the artificial tissues, but they did see the cells of the cancerous lung growing abnormally.
This could indicate that the artificial cancer cells are actually causing the cancer cells to develop abnormally and that the real cancer cells have been destroyed.
The artificial heart had a few other side effects that were not seen in the natural lungs, but these did not cause any adverse effects in the artificial tissue.
The researchers found that they could also block the artificial muscles in the cancer body by injecting a tiny amount of ALT6, which mimics a muscle.
When injected into cells in the lungs, ALTR6 blocked the growth of cancerous tumor cells.
This blocked the cancer cell from getting an opportunity to grow into a more malignant form.
The next step is to see if they can block the natural muscle cells in a person with cancer.
They also hope to make artificial hearts that are safe to inject into people with a variety of cancers.
They hope to eventually be able to inject them directly into the body.
“This is the first time we have been able to produce something that has this effect, and it is really exciting,” said MIT professor of biochemistry and molecular biology Daniel Rabinowitz, who led the work.
“We have engineered a protein that can act as a kind of natural muscle, which can stop the growths in cancerous cell lines.
We have engineered it to block cancer cells from growing.
We want to make these artificial organs that can give them a sense of control, to give them the ability to give up some of their health to help them survive.”
The MIT team also hopes to develop the artificial muscle to help people with cancer survive long-term.
The team is working on a model to see how this might work.
The research was funded by the National Institutes of Health, the National Science Foundation, the American Cancer Society and the Massachusetts Institute of Technology.
Follow AP Science for the latest in science news.